Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03577119 · ClinicalTrials.gov registry record · NA
Full-fat Yogurt and Glucose Tolerance
A NA study, sponsored by University of Vermont Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT03577119 is a NA study that has completed, run by University of Vermont Medical Center. The registered enrollment target is 13 participants.
The verdict
NCT03577119, a NA study, has completed, sponsored by University of Vermont Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
This study determines if substituting full-fat yogurt (i.e., whole, 3.25% fat) for non-fat yogurt in the diet can reduce the risk of type 2 diabetes and inflammation in association with changes in the composition of the gastrointestinal bacteria prediabetic male and female volunteers. The central hypothesis is that dairy fat impacts whole body glucose handling and insulin sensitivity as well as inflammation both directly, and indirectly via influencing the gut microbiota composition.
Interventions
- DIETARY_SUPPLEMENT Full-fat yogurt
- DIETARY_SUPPLEMENT Non-fat yogurt
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2018-06-01 |
| Est. Completion | 2022-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03577119
The ClinicalTrials.gov registry entry for NCT03577119 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Vermont Medical Center, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Full-fat yogurt is the first listed.
NCT03577119 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03577119 about?
NCT03577119 is a clinical study titled "Full-fat Yogurt and Glucose Tolerance". This study determines if substituting full-fat yogurt (i.e., whole, 3.25% fat) for non-fat yogurt in the diet can reduce the risk of type 2 diabetes and inflammation in association with changes in the composition of the gastrointestinal bacteria prediabetic male and female volunteers. The central hy...
What is the current status of trial NCT03577119?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2018-06-01. Estimated completion is 2022-06-30.
What interventions are being tested in trial NCT03577119?
The interventions under investigation include: Full-fat yogurt (DIETARY_SUPPLEMENT), Non-fat yogurt (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03577119?
This trial is sponsored by University of Vermont Medical Center, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.